The study will evaluate the effects of resveratrol/leucine and resveratrol/HMB for their
ability to control glucose levels in persons without diabetes but with impaired fasting
glucose. Secondary assessments will examine the effect of these nutritional supplements
versus placebo on inflammation, fasting lipids, HbA1C, and fructosamine, longer term
metabolic markers of risk in diabetes.